IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP

Cytokine

Volumn 11, Issue 7, 1999, Pages 469-475

  Boorsma, Dick M ^a   Flier, Jacoba ^a   Van Den Brink, Edward N ^a   Sampat, Shakun ^a   Walg, Hugo L ^a   Willemze, Rein ^a   Tensen, Cornelis P ^a   Stoof, Tom J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cAMP; Chemokine; IP 10; Protein kinase C; Tyrosine kinase

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CALPHOSTIN C; CYCLIC AMP; FORSKOLIN; GENISTEIN; INTERLEUKIN 18; MESSENGER RNA; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033045960     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0463     Document Type: Article

References (33)

1. Luster AD, Unkeless JC, Ravetch JV. γ-Interferon transcriptionally regulates an early response gene containing homology to platelet proteins. Nature. 315:1985;672-676.
2. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine. 3:1991;165-183.
3. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol. 12:1992;17-46.
4. Baggiolini M, DeWald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 55:1994;97-179.
5. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ. Recombinant human interferon-inducible protein 10 is a chemo-attractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 177:1993;1809-1814.
6. Loetscher M, Loetscher P, Jones SA, Piali L, Gerber B, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 184:1996;963-969.
7. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 101:1998;746-754.
8. Gottlieb AB, Luster AD, Posnett DN, Carter DM. Detection of a γ interferon-induced protein IP-10 in psoriatic plaques. J Exp Med. 168:1988;941-948.
9. Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med. 166:1987;1098-1108.
10. +lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood. 86:1995;651-658.
11. Tensen CP, Vermeer MH, van der Stoop PM, van Beek P, Scheper RJ, Boorsma DM, Willemze R. Epidermal interferon-γ inducible protein-10 (IP-10) and monokine induced by γ-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol. 111:1998;222-226.
12. Boorsma DM, DeHaan P, Willemze R, Stoof TJ. Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-γ-inducible protein (IP-10) gene expression in cultured normal human keratinocytes. Arch Dermatol Res. 286:1994;471-475.
13. Boorsma DM, Flier J, Sampat S, Ottevanger C, DeHaan P, Hooft L, Willemze R, Tensen CP, Stoof TJ. Chemokine IP-10 expression in cultured human keratinocytes. Arch Dermatol Res. 290:1998;335-341.
14. Mao C, Merlin G, Ballotti R, Metzler M, Aguet M. Rapid increase of the human IFN-γ receptor phosphorylation in response to human IFN-γ and phorbol myristate acetate. Involvement of different serine/threonine kinases. J Immunol. 145:1990;4257-4264.
15. Boorsma DM, Sampat S, Van den Brink E, Stoof TJ. IFN-γ-induced IP-10 mRNA expression in cultured human keratinocytes is under control of protein kinase-C, tyrosine kinase and cAMP. J Invest Dermatol. 107:1996.
16. Shuai K, Stark GR, Kerr IM, Darnell JE Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ Science. 261:1993;1744-1746.
17. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 15:1997;675-705.
18. Luster AD. N Engl J Med. 338:1998) Chemokines-chemotactic cytokines that mediate inflammation;436-445.
19. Gray LS, Gnarra J, Hewlett EL, Engelhard VH. Increased intracellular cyclic adenosine monophosphate inhibits T lymphocyte-mediated cytolysis by two distinct mechanisms. J Exp Med. 167:1988;1963-1968.
20. Bruynzeel I, van der Raaij LM, Willemze R, Stoof TJ. Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells. Arch Dermatol Res. 289:1997;189-193.
21. Haverstick DM, Gray LS. Lymphocyte adhesion mediated by lymphocyte function-associated antigen-1. II. Interaction between phorbol ester- and cAMP-sensitive pathways. J Immunol. 149:1992;397-402.
22. Flier J, Boorsma DM, van Beek PJ, Stoof TJ, Willemze R, Tensen CP. Differential expression of IFN-γ induced CXC chemokines IP-10 and Mig in inflammatory skin diseases. J Invest Dermatol. 110:1998.
23. Flier J, van der Stoop PM, van Beek PJ, Stoof TJ, Scheper RJ, Bruynzeel DP, Willemze R, Boorsma DM, Tensen CP. IP-10 mRNA is expressed in allergic but not in irritant contact dermatitis. J Invest Dermatol. 109:1997.
24. Griffiths CEM, Esmann J, Fisher GJ, Voorhees JJ, Nickoloff BJ. Differential modulation of keratinocyte intercellular adhesion molecule-I expression by gamma interferon and phorbol ester: evidence for involvement of protein kinase C signal transduction. Br J Dermatol. 122:1990;333-342.
25. Gupta AK, Fisher GJ, Elder JT, Nickoloff BJ, Voorhees JJ. Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity, and activation of protein kinase C in mouse skin. J Invest Dermatol. 91:1988;486-491.
26. Reynolds NJ, McCombie SW, Shankar BB, Bishop WR, Fisher GJ. SCH 47112, a novel staurosporine derivative, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and epidermal hyperplasia in hairless mouse skin. Arch Dermatol Res. 289:1997;540-546.
27. Hanifin JM, Chan SC, Cheng JB, Tofte SJ, Henderson WR Jr, Kirby DS, Weiner ES. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol. 107:1996;51-56.
28. Derian CK, Santulli RJ, Rao PE, Solomon HF, Barrett JA. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J Immunol. 154:1995;308-317.
29. Stoof TJ, van den Brink EN, Willemze R, Boorsma DM. Pentoxifylline (PTX) inhibits interferon-γ (IFN-γ) induced IP-10 mRNA expression on cultured human keratinocytes (KC). J Invest Dermatol. 103:1994.
30. Bruynzeel I, van der Raaij LM, Stoof TJ, Willemze R. Pentoxifylline inhibits T-cell adherence to keratinocytes. J Invest Dermatol. 104:1995;1004-1007.
31. Khetarpal VK, Markham PM, Ziemniak JA. Dispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application. Drug Metab Dispos. 22:1994;216-223.
32. Wang Y, E Y, Zhang X, Lebwohl M, DeLeo V, Wei H. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis. 19:1998;649-654.
33. Burke-Gaffney A, Hellewell PG. Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: modulation by tyrosine kinase inhibitors. Br J Pharmacol. 119:1996;1149-1158.